WOW!!! Today, a startup founded by two Poles announced the launch of Ataraxis Breast CTX, individualized chemotherapy benefit prediction test, and @Ataraxis_AI Tau, a causal inference platform!! A major breakthrough in the fight against breast cancer.

Ataraxis Breast CTX is the https://t.co/neD48PS7rK